A carregar...

FDA Intensifies Drive to Reduce REMS Burdens: The Key Objective Is to Ease Workflow Obstacles for Pharmacists

The FDA is working to solve problems with the often-confusing risk evaluation and mitigation strategy program, which covers 74 pharmaceuticals and four drug classes. Issues include patient access to drugs and the dominant role of specialty pharmacies.

Na minha lista:
Detalhes bibliográficos
Publicado no:P T
Autor principal: Barlas, Stephen
Formato: Artigo
Idioma:Inglês
Publicado em: MediMedia USA, Inc. 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4745637/
https://ncbi.nlm.nih.gov/pubmed/26909000
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!